Duloxetine
 
German Version French Version
 

Duloxetine

Duloxetine, (+)-(S)-N-Methyl-3-(naphyloxy)-3-(2-thienyl)propylamine, C18H19NOS, M 297,42

Serotonine and norepinephrine reuptake inhibitor (SNRI)

Brand name: Cymbalta, Yentreve

 

Application

Yentreve: women stress urinary incontinence (SUI)
Cymbalta: Treatment of moderate to severe major depressive disorders and diabetic peripheral neuropathy

Contraindications

Duloxetine should not be used in patients with: liver or kidney diseases, epileptic diseases, patients under 18 years.

Interactions

After treatment with MAO-inhibitors, Duloxetine should be taken only after expiration of a 14 days period, in order to avoid an occurrence of the serotonine syndrome.

Adverse Effects

In particular at the beginning nausea, tiredness or sleep disturbances arises. Further on sexual problems are reported. When the setting off from Duloxetin is too fast, fear conditions could arise with a potential higher suicide risk.

Custom Search

 

 

 

Last modification (M-D-Y): 02/08/2019 - IMPRINT - FAQ